KR810000520B1 - Process for purifying 5'-guanilic acid - Google Patents

Process for purifying 5'-guanilic acid Download PDF

Info

Publication number
KR810000520B1
KR810000520B1 KR1019800002680A KR800002680A KR810000520B1 KR 810000520 B1 KR810000520 B1 KR 810000520B1 KR 1019800002680 A KR1019800002680 A KR 1019800002680A KR 800002680 A KR800002680 A KR 800002680A KR 810000520 B1 KR810000520 B1 KR 810000520B1
Authority
KR
South Korea
Prior art keywords
guanylic acid
acid
particles
crystal
separated
Prior art date
Application number
KR1019800002680A
Other languages
Korean (ko)
Inventor
배종찬
이희인
문화식
조영제
Original Assignee
제일제당 주식회사
경주현
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제일제당 주식회사, 경주현 filed Critical 제일제당 주식회사
Priority to KR1019800002680A priority Critical patent/KR810000520B1/en
Application granted granted Critical
Publication of KR810000520B1 publication Critical patent/KR810000520B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

High purity 5'-guanylic acid(I) crystals were prepd. by seed-crystallization of impurities-contg. I soln. at 0.5-1.0 pH, 3-5≰C, 5hr. Thus, 500 g INa was dissolved in 6L H2O and small amount of columnar seed was added to the soln. followed by stirring at pH 0.7, 5≰C, to grow crystal, which was sepd. to give 358 g free crystal I. The crystal I was obtained by pptn. and filtration of the free crystal in 2L H2O(pH 8.2), 60% MeOH.

Description

5'-구아닐산의 정제법Purification of 5'-Guanylic Acid

제1도는 정석시간에 따른 5'-구아닐산의 침전율을 나타낸 그래프.1 is a graph showing the precipitation rate of 5'-guanylic acid according to the crystallization time.

제2도는 본 발명에 의해서 분리된 5'-구아닐산 유리형결정을 나타낸 현미경 사진(배율 100배)2 is a micrograph (100 times magnification) showing 5'-guanylic acid free crystals separated by the present invention.

본 발명은 특정한 pH의 범위안에서 5'-구아닐산(5'-Guang sine mono phosphate)을 높은 수율로 5'-구아닐산의 유리형으로 정제하는 방법에 관한 것이다.The present invention relates to a process for purifying 5'-Guang sine mono phosphate to free form of 5'-guanylic acid in a high yield within a specific pH range.

현재까지 5'-구아닐산은 생체조직의 추출, 리보헥산의 가수분해, 직접발효 및 합성법등으로 제조되었고, 이렇게 제조된 5'-구아닐산 함유액에 대한 정제방법이 다수 발명되었다. 예를들면 방향족 탄소산과 난용성 화합물로 해서 침전시켜 분취하거나, 5'-구아닐산의 함유액에 우리딜산을 첨가하여 화합물을 생성시켜 pH1-5에서 5'-구아닐산 화합물로 정제하거나, 또는 1.4-디옥산(dioxane) 화합물로 생성시켜 분리하는 방법을 사용하기도 하고 또, 강산성 양이온 교환수지, 강염기성 음이온 교환수지, 비이온성 교환수지 및 활성탄을 단일 혹은 복합으로 흡착시켜 여러 종류의 유기, 무기물의 단독 또는 혼합액으로 선택적으로 분별 정제하는 방법등이 있었다.To date, 5'-guanylic acid has been prepared by extraction of biological tissues, hydrolysis of ribohexane, direct fermentation, and synthesis, and the like, and various purification methods for the 5'-guanylic acid-containing liquid thus prepared have been invented. For example, precipitated and fractionated as an aromatic carbonic acid and a poorly soluble compound, or by adding uridil acid to a solution containing 5'-guanylic acid, the compound is produced and purified to a 5'-guanylic acid compound at pH1-5, or 1.4-di It is sometimes used to produce and separate dioxane compounds.Also, strong acidic cation exchange resins, strong basic anion exchange resins, nonionic exchange resins, and activated carbon can be adsorbed in a single or a combination of various organic or inorganic substances. There has been a method of selectively purifying with a mixed solution.

이러한 종래의 방법을 좀더 상세히 설명하면, 5'-구아닐산 함유액을 pH1.0-5.0에서 5'-구아닐산이 유리형 또는 모노소디움(mono sodium)염으로 분리하는 방법등이 있으나, 이러한 방법은 5'-구아닐산의 물성중 pH1.5-6.0사이에서는 겔(Gel)이 형성되어 결정화가 난이하다는 성질이 있고 또 결정전 5'-구아닐산 함유액의 농도를 높일 수 없는 공업적 폐단이 있을 뿐 아니라, pH1.0-5.0에서 저농도의 5'-구아닐산 함유액을 유리형 및 모노소디움(mono sodium)염으로 형성시킬 경우, 불순물인 색소 및 단백질등의 동전점(isoelectric point)영역이므로 불순물이 공침되어 순도가 저하되며, 분리성이 양호한 결정상을 얻을 수 없었다. 또, 일부 정제되어 농축된 액에 유기용매 첨가에 의한 5'-구아닐산의 분리방법에서는 메타놀 및 에타놀, 아세톤(Acetoee) 등의 친수성 유기용매에 공침되는 색소 및 단백질등의 석출로 인해 제품의 품질저하로 재탈색 및 재결공정을 행하여야만 한다는 결점이 있었다.To describe in more detail such a conventional method, there is a method in which the 5'-guanylic acid-containing solution is separated into free or monosodium salt of 5'-guanylic acid at pH 1.0-5.0, but such a method is 5 In the physical properties of '-guanylic acid, the gel is formed between pH 1.5-6.0 and crystallization is difficult, and there is an industrial discontinuity that cannot raise the concentration of the 5'-guanylic acid solution before crystallization. When the low concentration of 5'-guanylic acid-containing solution is formed in the form of free and mono sodium salt at .0-5.0, it is an isoelectric point region such as pigments and proteins, which are impurities, It was lowered and a crystal phase with good separability could not be obtained. In addition, the separation method of 5'-guanylic acid by the addition of organic solvent to the partially purified and concentrated solution is the degradation of product quality due to precipitation of pigments and proteins which are co-precipitated in hydrophilic organic solvents such as methanol, ethanol and acetone. There was a drawback that the rebleaching and recrystallization process must be performed.

다시말해, 종래의 방법으로는 5'-구아닐산 함유액의 정제를 용이하게 할 수 없을 뿐만 아니라 대량생산을 할 수 있는 적합한 방법등, 높은 수율로 분별정제할 수 없는 결점이 있었던 것이다.In other words, the conventional method is not only able to facilitate the purification of the 5'-guanylic acid-containing liquid, but also has a disadvantage in that it cannot be fractionated and purified in high yield, such as a suitable method for mass production.

본 발명자들은 종래기술의 상기와 같은 결점을 해결할 뿐 아니라 경제적으로도 유리한 5'-구아닐산정제법을 꾸준히 연구 실험한 결과, 5'-구아닐산은 산성영역에서는 유리형으로 존재하거나, 모노소디움(mono sodium)염으로 존재하며, 또 pH 1 이하에서는 유리형으로 되어 지극히 난용성으로되는 성질등을 이용하므로서 결정성이 좋고 분리가 용이한 주상형의 5'-구아닐산을 유리형으로 분리시킬 수 있음을 알 수 있었다.The present inventors have steadily solved the above-mentioned drawbacks of the prior art, and have continued to study economically advantageous 5'-guanylic acid purification methods. As a result, 5'-guanylic acid is present in the free form in the acidic region or monosodium (mono sodium). It can be seen that it can be separated into 5'-guanylic acid having a good crystallinity and easy separation by using the property that it exists as a salt and becomes less than pH 1 and becomes extremely poorly soluble. Could.

이러한 본원 발명을 상세히 설명하면, 5'-구아닐산 함유액을 강산성 양이온 교환수지를 통과시켜 흡착시키고, 물로 용리하여 그 용리액을 강염기성 음이온 교환수지에 흡착시켜 1.5-1.0 N HCl로 용리하여 5'-구아닐산 80g/ℓ의 액 5ℓ을 얻었다.The present invention will be described in detail. The 5'-guanylic acid-containing solution is adsorbed through a strong acid cation exchange resin, eluted with water, and the eluent is adsorbed on a strong basic anion exchange resin, eluted with 1.5-1.0 N HCl, and eluted with 5'-. 5 L of guanilic acid 80 g / L was obtained.

이 액에 6N HCl 용액으로 pH를 0.7로 조종하여 온도를 강하시키면서 별도로 분리한 주장형의 입자(Seed)를 첨가하여 3-5℃로 유지하면서 교반하였다.To this solution, the pH was adjusted to 0.7 with 6N HCl solution to decrease the temperature, and then separately added allied particles (Seed) were added and stirred while maintaining at 3-5 ° C.

이때 분리한 주상형입자(Seed)를 첨가하지 않으면 다아야몬드형의 입자 및 침상형의 입자가 지연정석되어 순도가 저하되고 분리성이 나빠지는 원인이 된다.At this time, if the separated columnar particles (Seed) is not added, the diamond particles and needle-like particles are delayed crystallization, resulting in a decrease in purity and poor separability.

[표 1]TABLE 1

정석시간에 따른 침전율 변화Sedimentation Rate Changes According to Crystallization Time

Figure kpo00001
Figure kpo00001

표 1에서 나타난 바와 같이 본발명은 5'-구아닐산 함유액의 정석을 1시간이상하면 5'-구아닐산의 70%이상이 크고 깨끗한 주상형 입자로 형성되었으며, 4시간동안 교반후 생성된 침전을 여과하고 소량의 물로 세척, 건조하여 283g의 5'-구아닐산의 유리형으로 분리하였다.As shown in Table 1, in the present invention, when the crystallization of the 5'-guanylic acid-containing solution is more than 1 hour, 70% or more of 5'-guanylic acid is formed into large, clean columnar particles, and the resulting precipitate is filtered after stirring for 4 hours. And washed with a small amount of water and dried to separate 283 g of 5'-guanylic acid into a free form.

이때 정석액중의 타(他)이온(Other lon) 및 단백질, 색소등의 불순물은 결정모액으로 제거할 수 있는 것이 본 발명의 특징의 하나다.At this time, other ions in the crystallization solution, impurities such as proteins and pigments can be removed with a crystal mother solution, which is one of the characteristics of the present invention.

[표 2]TABLE 2

pH 및 시간에 따른 5'-구아닐산의 안정성(농도 : g/ℓ)Stability of 5'-guanylic acid with pH and time (concentration: g / l)

Figure kpo00002
Figure kpo00002

또한 본원 발명은 표 2에서 나타난 바와같이 5℃의 온도상태에서 pH0.7의 함유액이 12시간까지도 5'-구아닐산은 분해되지 않고 안정하다는 것을 알 수 있었고, 이 유리형의 결정을 1.2ℓ의 물에 현탁시켜 NaOH로 pH8.0으로 조정하여 용해시키고 MeOH를 60%가 되도록 첨가하여 5'-구아닐산나트륨의 결정을 생성시키고 이를 분리건조하여 5'-구아닐산나트륨 352g을 얻을 수 있었다.In addition, as shown in Table 2, it was found that 5'-guanylic acid was stable without degradation in the solution containing pH 0.7 even at a temperature of 5 ° C. for up to 12 hours. It was suspended in water, adjusted to pH 8.0 with NaOH, dissolved, and added MeOH to 60% to produce crystals of 5'- sodium guanylate, which was separated and dried to obtain 352 g of 5'- sodium guanylate.

이하 본원 발명을 실시예에 의하여 좀더 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in more detail with reference to Examples.

[실시예 1]Example 1

5'-구아닐산 나트륨 500g을 물 6ℓ에 용해하고 pH0.7로 조정하여 온도를 5℃로 유지시키면서 자연입자가 형성되기 전에 미리 분리된 주상입자를 소량 첨가하여 5시간 교반시켰다. 이때 형성된 입자를 분리하여 5'-구아닐산의 유리형 358g을 얻고, 이 습정을 2ℓ의 물에 용해시키고 6N-NaOH로 pH8.2로 조정하여 MeOH로 60%가 되도록 참가하여 형성된 5'-구아닐산 나트륨 결정 441g을 얻었다.500 g of 5'- sodium guanylate was dissolved in 6 l of water, adjusted to pH 0.7, and stirred for 5 hours by adding a small amount of previously separated columnar particles before natural particles were formed while maintaining the temperature at 5 ° C. At this time, the formed particles were separated to obtain a free 358 g of 5'-guanylic acid, and this wet tablet was dissolved in 2 L of water and adjusted to pH8.2 with 6N-NaOH to form 60% with MeOH. Sodium 5'-guanylate 441 g of crystals were obtained.

[실시예 2]Example 2

직접발효에 의해 농도 19g/6ℓ의 5'-구아닐산 함유액을 진공여과하여 균체 및 불용성 물질을 제거한 액 5ℓ을 4ℓ의 강산성 양이온 교환수지에 5'-구아닐산을 흡착시켜 기타 누클레오타이드(Nucleotide) 및 누클레오시드(Nucleoside), 색소 불순물등을 제거한후 탈염수로 용리하고 그 용리액을 강염기성 음이온 교환수지 0.45ℓ에 흡착시켜 0.5N-NaCl로 용리하여 5'-구아닐산 70g/ℓ의 용리액 1.25ℓ를 얻었고 그액의 pH는 0.8이었다. 이 용리액을 냉각시키면서 주상형의 입자(Seed)를 소량 첨가하여 5℃에서 4시간 교반후 형성된 입자를 분리하여 건조시킨 결과 5'-구아닐산 유리형 60.7g을 얻었다.Directly fermentation 5g of 5'-guanylic acid containing 19g / 6l of liquid containing 5'-guanylic acid to remove cells and insoluble matters was adsorbed on 4l strong acid cation exchange resin to adsorb 5'-guanylic acid to other nucleotides (Nucleotide) and Nucleoside and pigment impurities were removed, eluted with demineralized water, and the eluent was adsorbed on 0.45 L of strong basic anion exchange resin, eluted with 0.5 N-NaCl to obtain 1.25 L of 5'-guanylic acid 70 g / L. The pH of the liquid was 0.8. While cooling the eluent, a small amount of columnar particles (Seed) was added, and after stirring for 4 hours at 5 ° C, the formed particles were separated and dried to obtain 60.7 g of 5'-guanylic acid glass.

Claims (1)

5'-구아닐산 함유액 및 일부 불순물이 제거되거나 농축된 액의 pH를 0.5-1.0으로 조정한 후 3-5℃로 유지하면서 분리된 입자(Seed)를 첨가하여 5시간 정석하여 분리성이 양호한 고순도의 5'-구아닐산 유리형결정을 선택적으로 침전시켜 정제하는 것을 특징으로 하는 5'-구아닐산의 정제법.The pH of the 5'-guanylic acid-containing solution and some of the impurities removed or concentrated is adjusted to 0.5-1.0, and the particles are separated by adding separated particles (Seed) while maintaining the temperature at 3-5 ° C for high purity with good separation. Purification of 5'-guanylic acid, characterized by selectively precipitated and purified 5'-guanylic acid free crystals.
KR1019800002680A 1980-07-07 1980-07-07 Process for purifying 5'-guanilic acid KR810000520B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019800002680A KR810000520B1 (en) 1980-07-07 1980-07-07 Process for purifying 5'-guanilic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019800002680A KR810000520B1 (en) 1980-07-07 1980-07-07 Process for purifying 5'-guanilic acid

Publications (1)

Publication Number Publication Date
KR810000520B1 true KR810000520B1 (en) 1981-05-25

Family

ID=19217049

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800002680A KR810000520B1 (en) 1980-07-07 1980-07-07 Process for purifying 5'-guanilic acid

Country Status (1)

Country Link
KR (1) KR810000520B1 (en)

Similar Documents

Publication Publication Date Title
TW293822B (en)
KR810000520B1 (en) Process for purifying 5'-guanilic acid
JPH08333312A (en) Purification of valine
CA3058886C (en) Method for manufacturing diastereomer of citric acid derivative
US4399304A (en) L-phenylalanine 1/2 sulfate and its use
KR100210325B1 (en) Process for producing crystalline 7-beta-amino-3-(5-carboxymethyl-4-methyl-1,3-thiazol-2-yl-thiome thyl)-ceph-3-em-4-carboxylic acid
JPS624399B2 (en)
US3360554A (en) Process for crystallizing out l-glutamic acid
EP0000745A1 (en) Salt of an optically active isomer of phenylglycine and an optically active isomer of 2-amino butanol and process for its preparation
JPS6231915B2 (en)
EP0126886B1 (en) Process for the separation of l-leucine and l-isoleucine
US3692781A (en) Recovery of pure cephalexin from acidic reaction mixtures
US4551548A (en) Process for the recovery of S-(carboxymethyl)-(R)-cysteine and S-(carboxymethyl)-(S)-cysteine
JP2877366B2 (en) Method for producing crystalline L-ascorbic acid-2-phosphate sodium salt
US3862132A (en) Optical resolution of dl-2-pyrrolidone-5-carboxylic acid
EP0081831B1 (en) Process for purifying elastase
JPS62148459A (en) Separation and purification of glutamine
US3206506A (en) Separation of acetylglutamine
JP3525223B2 (en) Method for selective crystallization of guanosine monosodium salt dihydrate
KR910006620B1 (en) Process for making calcium grutamic acid
JPS61293383A (en) Separation and recovery of nosiheptide
JP2022550078A (en) Method for producing disodium 5'-guanylate heptahydrate crystals
JPH0629142B2 (en) Method for producing yttrium iron garnet powder
CN111574576A (en) Refining method of diquafosol sodium
JPS60105498A (en) Recovery of optically active tryptophan